Cargando…

514. Anti-SARS-CoV-2 Monoclonal Antibodies for Early COVID-19: A Real World Experience

BACKGROUND: Anti-SARS-CoV-2 monoclonal antibodies afford prompt immunity, have demonstrated reduction in severe COVID-19 in high risk ambulatory patients, and are available through Emergency Use Authorization. Challenges exist, however, to widespread utilization. METHODS: This operations study 11/23...

Descripción completa

Detalles Bibliográficos
Autores principales:	Belden, Katherine, Hess, Bryan, Brugger, Caroline, Carr, Rachel, Braun, Todd, DeRose, Joseph L, Zurlo, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690787/ http://dx.doi.org/10.1093/ofid/ofab466.713

Ejemplares similares

P514: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES OF MOLECULAR SUBGROUPS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING FRONTLINE VENETOCLAX-BASED THERAPY
por: Lachowiez, Curtis, et al.
Publicado: (2023)

479. Real-world Evaluation of SARS-CoV-2 Monoclonal Antibodies in Solid Organ Transplant Recipients
por: Zeitler, Kristen, et al.
Publicado: (2021)

Do Monoclonal Antibody Therapies Improve 'Real-World' Outcomes of COVID-19 in Patients with Lymphoid Malignancies? the UT Southwestern Experience
por: Sannareddy, Aishwarya, et al.
Publicado: (2022)

Stochastic Reaction–Diffusion Model of the Binding of Monoclonal Antibodies to CD4 Receptors on the Surface of T Cells
por: Wang, Lili, et al.
Publicado: (2020)

5.14 The Biophysics of Membrane Fusion
por: Collins, R.N., et al.
Publicado: (2012)

Real-world Effectiveness and Tolerability of Monoclonal Antibody Therapy for Ambulatory Patients With Early COVID-19
por: Webb, Brandon J, et al.
Publicado: (2021)

514. The Effect of Probiotics on the Incidence of Clostridium difficile
por: Saltzman, Temima, et al.
Publicado: (2018)

514 The Outcomes of Tracheostomy on Burn Inhalation injuries
por: Ruiz, Samuel G, et al.
Publicado: (2022)

514. Clinical features and outcomes of 112 patients with SARS-CoV-2 infections requiring intensive care in a public healthcare system in South Florida
por: Niu, Jianli, et al.
Publicado: (2020)

Monoclonal antibodies for chronic migraine and medication overuse headache: A real-world study
por: Krymchantowski, Abouch V., et al.
Publicado: (2023)

Novel monoclonal antibodies against pathogenic Leptospira
por: de Matos, Bruno Moisés, et al.
Publicado: (2014)

1270. Early Real-world Evidence in the Use of Eravacycline for the Management of Draconian Infections
por: Carr, Amy, et al.
Publicado: (2020)

The distinct role of strand-specific miR-514b-3p and miR-514b-5p in colorectal cancer metastasis
por: Ren, Lin-Lin, et al.
Publicado: (2018)

Real-World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 Outpatients
por: Wynia, Matthew K., et al.
Publicado: (2023)

Technological and methodical process integration in manufacturing of monoclonal antibodies
por: Gronemeyer, Petra, et al.
Publicado: (2015)

554. Clinical Impact of Monoclonal Antibody Therapy with SARS-CoV-2 Infection
por: Mann, Inderjit, et al.
Publicado: (2021)

Investigation of antibody dependent cellular cytotoxicity as a mechanism of action for a novel anti-PD-L1 monoclonal antibody
por: Boyerinas, Benjamin, et al.
Publicado: (2014)

Economic evaluation of monoclonal antibody in the management of colorectal cancer in Malaysia
por: Natrah, MS, et al.
Publicado: (2012)

Rapid desensitization in delayed hypersensitivity reactions to chemotherapy and monoclonal antibodies
por: Vega, Arantza, et al.
Publicado: (2014)

Real-world evidence data on the monoclonal antibody erenumab in migraine prevention: perspectives of treating physicians in Germany
por: Straube, Andreas, et al.
Publicado: (2021)

A real-world assessment of tolerability and treatment outcomes of COVID-19 monoclonal antibodies administered in pregnancy
por: Chang, Mei H., et al.
Publicado: (2022)

Antagonist properties of monoclonal antibodies to human CD28: role of valency and heavy-chain constant domain
por: Mary, Caroline, et al.
Publicado: (2012)

1383. Characterizing Real-world Patterns of Early Childhood Vaccination
por: Butler, Anne M, et al.
Publicado: (2020)

Evaluation of neonatal outcomes in COVID-19 positive mothers who received monoclonal antibodies
por: Chen, Katherine, et al.
Publicado: (2023)

762. Real-World Utilization of C. difficile Drug Treatments and Associated Clinical Outcomes in a US Hospital System
por: McDaniel, Lauren, et al.
Publicado: (2021)

P1025: A PILOT STUDY OF THE ANTI-SLAMF7 MONOCLONAL ANTIBODY, ELOTUZUMAB, IN PATIENTS WITH MYELOFIBROSIS.
por: Bose, Prithviraj, et al.
Publicado: (2023)

Evaluation of allergic reactions from different monoclonal antibodies used for COVID-19 in pregnancy
por: Chen, Katherine, et al.
Publicado: (2023)

Geographic and Socioeconomic Disparity in Child Undernutrition across 514 Districts in Indonesia
por: Ayuningtyas, Dumilah, et al.
Publicado: (2022)

Disparities in Obesity Rates among Adults: Analysis of 514 Districts in Indonesia
por: Ayuningtyas, Dumilah, et al.
Publicado: (2022)

P1134: OUTCOMES FOR PATIENTS WITH MANTLE CELL LYMPHOMA POST-CBTK INHIBITOR THERAPY IN THE UNITED STATES AND JAPAN: A STUDY OF TWO REAL-WORLD DATABASES
por: Rai, S., et al.
Publicado: (2022)

Amelioration of joint inflammation by a PAR-2-specific monoclonal antibody
por: King, V, et al.
Publicado: (2005)

In silico prediction of the neutralization range of human anti-HIV monoclonal antibodies
por: Shmelkov, E, et al.
Publicado: (2012)

Partial characterization of two novel monoclonal antibodies for Listeria spp. Immunodetection
por: Moreira, Gustavo, et al.
Publicado: (2014)

Novel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretin
por: Higaki, Jeffrey N, et al.
Publicado: (2015)

Developing an upstream process for a monoclonal antibody including medium optimization
por: Duvar, Sevim, et al.
Publicado: (2013)

60: The real-world effectiveness of U.S. CF newborn screening
por: Rosenfeld, M., et al.
Publicado: (2021)

P948: REAL-WORLD EVIDENCE OF BISPHOSPHONATES FOR MULTIPLE MYELOMA
por: Muñoz, Maria Nieves Lopez, et al.
Publicado: (2023)

P541: REAL-WORLD USE OF VENETOCLAX (VEN) IN PATIENTS (PTS) WITH ACUTE MYELOID LEUKEMIA (AML) IN A US REAL-WORLD EVIDENCE DATABASE (COTA)
por: Zeidan, Amer M., et al.
Publicado: (2023)

Real-world Effect of Monoclonal Antibody Treatment in COVID-19 Patients in a Diverse Population in the United States
por: Rainwater-Lovett, Kaitlin, et al.
Publicado: (2021)

Real-world experience of monoclonal antibodies in mild-to-moderate COVID-19 patients at a tertiary care center
por: Marwah, Vikas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jsi47btj8f8a8d6pkq7e1b76v0